Rebecca Liang

Stock Analyst at Bernstein

(4.26)
# 1,339
Out of 4,345 analysts
75
Total ratings
58.3%
Success rate
23.4%
Average return

Stocks Rated by Rebecca Liang

Hansoh Pharmaceutical Group Company Limited
Apr 22, 2026
Maintained: Buy
Price Target: $44.00$47.00
Current: $33.42
Upside: +40.63%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Mar 26, 2026
Maintained: Buy
Price Target: $545.00$526.00
Current: $462.60
Upside: +13.71%
BeOne Medicines AG
Mar 18, 2026
Maintained: Buy
Price Target: $412
Current: $302.44
Upside: +36.23%
Akeso, Inc.
Mar 18, 2026
Maintained: Hold
Price Target: $130.00
Current: $115.60
Upside: +12.46%
Innovent Biologics, Inc.
Mar 12, 2026
Maintained: Buy
Price Target: $115.00
Current: $78.60
Upside: +46.31%
Sino Biopharmaceutical Limited
Feb 9, 2026
Maintained: Hold
Price Target: $7.90
Current: $4.96
Upside: +59.27%
CSPC Pharmaceutical Group Limited
Feb 9, 2026
Maintained: Hold
Price Target: $10.70
Current: $7.26
Upside: +47.38%
Zai Lab Limited
Feb 9, 2026
Maintained: Hold
Price Target: $18.00
Current: $14.25
Upside: +26.32%